| module1 |
GO:0000922~spindle pole(CC) |
4 |
2.42E-05 |
2.13E-02 |
CCNB1, KIF11, MAD2L1, PRC1 |
| GO:0051301~cell division(BP) |
5 |
3.53E-05 |
3.95E-02 |
CCNB1, KIF2C, KIF11, MAD2L1, CCNB2 |
| GO:0015630~microtubule cytoskeleton(CC) |
4 |
4.80E-05 |
4.22E-02 |
KIF2C, CCNB2, PRC1, MCM2 |
| module2 |
hsa05200:Pathways in cancer(KEGG) |
8 |
7.41E-05 |
8.34E-02 |
ADCY1, CDKN2A, BCR, CDKN2B, RXRA, BCL2, GNB5, GNAS |
| GO:0071456~cellular response to hypoxia(BP) |
4 |
2.58E-04 |
3.71E-01 |
BCL2, PPARGC1A, SLC9A1, PCK1 |
| GO:0042493~response to drug(BP) |
5 |
5.95E-04 |
8.55E-01 |
ADCY1, BCL2, GNAS, PPARGC1A, SLC9A1 |
| module3 |
hsa04310:Wnt signaling pathway(KEGG) |
7 |
4.55E-09 |
3.09E-06 |
WNT5A, DKK2, FRAT1, FRAT2, WIF1, LRP5, APC |
| GO:1904886~beta-catenin destruction complex disassembly(BP) |
4 |
2.33E-07 |
2.95E-04 |
FRAT1, FRAT2, LRP5, APC |
| GO:0016055~Wnt signaling pathway(BP) |
5 |
2.97E-06 |
3.76E-03 |
WNT5A, DKK2, WIF1, LRP5, APC |
